[Clinical studies on doxycycline treatment of urogenital Chlamydia trachomatis infections].
Nineteen patients of male NGU and 8 patients of female NGC were treated with doxycycline (DOXY, 200 mg/day for 14 days). C. trachomatis positive rate of male NGU was 12/19 (63%), and that of female NGC was 4/8 (50%). C. trachomatis positive rate of male NGU after treatment of DOXY for 3 days, 7 days and 14 days, was 83%, 17% and 0%, respectively. Serous discharge after treatment of DOXY for 3 days, 7 days, 14 days, was continued in 100%, 33%, 0%. Administration of DOXY (200 mg/day for 14 days) was considered good treatment for male C. trachomatis positive NGU.
T
T
Tsunekawa
Y
Y
Kumamoto
S
S
Sakai
K
K
Hayashi
T
T
Gohro
D002690:Chlamydia Infections / Q000188:drug therapy* / Q000652:urine; D002692:Chlamydia trachomatis / Q000302:isolation & purification; D004318:Doxycycline / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D013997:Time Factors; D014526:Urethritis / Q000188:drug therapy* / Q000652:urine; D014556:Urine / Q000382:microbiology; D002575:Uterine Cervicitis / Q000188:drug therapy* / Q000652:urine
D004318:Doxycycline